A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Quinton, A ^a   Lewis, P ^b   Ali, P ^a   Morgan, C ^b   Bertelli, G ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Carboplatin; Cockcroft Gault; Jelliffe; Renal function; Seminoma; Wright

Indexed keywords

CARBOPLATIN; CREATININE; EDETATE CHROMIUM CR 51;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DOSE CALCULATION; EARLY CANCER; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMINOMA; SINGLE DRUG DOSE; AREA UNDER THE CURVE; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TESTIS TUMOR; YOUNG ADULT; DRUG EFFECTS; TESTICULAR NEOPLASMS;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; CARBOPLATIN; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 84880085716     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0661-1     Document Type: Article

References (19)

1. Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21(Suppl 5):v140-6.
2. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, von der Maase H. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20(22):4448-52.
3. Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005;366(9482):293-300.
4. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989;7(11):1748-56.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
6. Jelliffe RW. Letter: creatinine clearance: bedside estimate. Ann Intern Med. 1973;79(4):604-5.
7. Wright JG, Boddy AV, Highley M, Fenwick J, McGill A, Calvert AH. Estimation of glomerular filtration rate in cancer patients. Br J Cancer. 2001;84(4):452-9.
8. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med. 1916; 17:863-71.
9. Brochner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972;30(3): 271-4.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-10.
11. Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH. Flat dosing of carboplatin is justified in adult patients with normal renal function. Clin Cancer Res. 2006;12(21): 6502-8.
12. Gore M. Carboplatin equals cisplatin: but how do I prescribe it? J Clin Oncol. 2003;21(17):3183-5.
13. Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol. 2011;29(8): 957-62.
14. Marx GM, Blake GM, Galani E, Steer CB, Harper SE, Adamson KL, Bailey DL, Harper PG. Evaluation of the Cockcroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol. 2004;15(2):291-5.
15. Poole SG, Dooley MJ, Rischin D. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients. Ann Oncol. 2002; 13(6):949-55.
16. Holweger K, Lipp HP, Dietz K, Hartmann JT, Bokemeyer C. Novel algorithm for more accurate calculation of renal function in adults with cancer. Ann Pharmacother. 2008;42(12):1749-57.
17. Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffem, Wright or Chatelut formula. Gynecol Oncol. 2005;99(2):327-33.
18. de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol. 2006;103(3):1063-9.
19. Faluyi OO, Masinghe SP, Hayward RL, Clive S. Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment. Med Oncol. 2012;29(2):755-60.